Navigation Links
Wistar receives $1.5 million Department of Defense grant to ready prostate drug for clinical use
Date:9/12/2013

nd are currently in the clinic, they have limited activity in cancer patients. This may reflect their inability to inhibit HSP90 in mitochondria, which are protected by their own membrane. Using combinatorial chemistry, Altieri and his colleagues created a molecule that would both target HSP90 and accumulate in mitochondria.

"Gamitrinib is, essentially, a two-piece molecule, one part drives it into mitochondria and the other inhibits HSP90," said Altieri. "This became a promising drug concept, one that might apply to multiple forms of advanced cancer, because only cancer cells seem to exploit mitochondrial HSP90 in relevant amounts."

Gamitrinib exploits a critical weakness of cancer cells. While mitochondria control energy production, they also control the inherent self-destruct mechanism within cells, a process called programmed cell death or apoptosis. It is a mechanism that is relevant to many forms of metastatic cancer, and Altieri believes that, in time, the drug will be used to treat many cancers in addition to prostate cancer. Over years of study, the Altieri laboratory has demonstrated how Gamitrinib can prime cancer cell mitochondria for destruction in cell cultures and animal models for many advanced forms of cancer.

The Department of Defense grant will enable the Altieri laboratory to make the final leap between laboratory science and trials in human subjects. The funds will allow Wistar to contract with third-party research organizations to conduct the formulation, toxicology, and pharmacology studies to demonstrate the drug's effectiveness and safety in anticipation of human trials. The funds will also support the development of a suitable biomarkera biological signature that could be measured in patients to demonstrate the effectiveness of Gamitrinib-based therapy.

"In our studies we have shown the mechanism by which Gamitrinib works and potential drug combinations that will kill metastatic prostate cancer cells mo
'/>"/>

Contact: Greg Lester
glester@wistar.org
215-898-3934
The Wistar Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Wistar scientists decipher structure of NatA, an enzyme complex that modifies most human proteins
2. High folate gestational and post-weaning diets in Wistar rat offspring
3. It takes two to tangle: Wistar scientists further unravel telomere biology
4. UCSF receives $4.5M to study value of gene sequencing in newborns
5. Wayne State receives grant to reduce emissions of toxins by power plants into Great Lakes
6. International Rett Syndrome Foundation chief science officer receives prestigious military awards
7. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
8. Wayne State receives NSF grant to develop plan for field-based water research center
9. VCU receives NIH grant to examine the biology of allergic disease
10. Carnegies Chris Field receives Max Planck Research Prize
11. Penn receives prestigious national award for breakthrough in gene therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... world-leading provider of scientific, technical and medical information ... Society (ARMS), recognized the academic research achievements of ... Researcher of the Year Awards. , The award ... Centre and in conjunction with the ARMS 2014 ... and New Zealand,s scientific community. Guest of honour ...
(Date:9/18/2014)... can swim up to 400 kilometres in search of a ... change. , Clownfish spend their entire adult lives under the ... wander the open ocean, says study co-author, Dr Hugo Harrison ... (Coral CoE) at James Cook University. , "In the past ... given a rare glimpse into how far they can swim, ...
(Date:9/17/2014)... the Arts and Humanities has received a $260,000 grant ... project, "The Boundaries of the Human in the Age ... a wide-ranging series of events aimed at exploring two ... artists and researchers who are exploring the boundaries of ... humanism, and the other involves the increasingly influential hypothesis ...
Breaking Biology News(10 mins):Elsevier and Australasian Research Management Society award scientists at Scopus ceremony 2Nemo's epic journey to find a new home 2Mellon Foundation awards grant for major project in the humanities and sciences 2
... 31 January 2014 VIB and CD3 (KU Leuven) ... agreement with AstraZeneca for the development of novel MALT1 ... The research teams of Thijs Baens and Peter ... Beyaert (VIB-UGent, Inflammation Research Center) were among the first ...
... University have just published a comprehensive overview of forensic research ... "By pulling all of this information together in one ... some children and find justice for others," says Dr. Ann ... author of the paper. Ross is also co-editor of the ...
... were domesticated more than 15,000 years ago and it ... to form close relationships with humans stems from changes ... on the interactions between the animals have not received ... Range and Zsfia Virnyi, two members of the University ...
Cached Biology News:VIB&CD3 enter into license and collaboration agreement with AstraZeneca for development of MALT1 inhibitor 2Forensic experts compile guide on how to ID child abuse, starvation 2Teaching young wolves new tricks 2
(Date:9/18/2014)... LOUIS , Sept. 18, 2014  U.S. biotech ... by signing an exclusive license for technology developed by ... control gene expression in plants, including for applications in ... The technology was developed under the ... officer at Kultevat and former president of the Danforth ...
(Date:9/18/2014)...  Neogen Corporation (Nasdaq: NEOG ) announced ... with Merck Animal Health to market Neogen,s Igenity ® ... Dairy Heifer Program consists of genomic tests that offer ... of replacement dairy heifers. The genomic tests can be ... an excellent tool in the decision-making process for breeding ...
(Date:9/18/2014)... YARDLEY , Pennsylvanie, 18 septembre 2014 ... Lyon en 1974, a été ... à compléter les évaluations cliniques traditionnelles par ... Reported Outcomes) et sur les impacts économiques ... http://photos.prnewswire.com/prnh/20140618/119365 A cours ...
(Date:9/18/2014)... OMICS Group International invites researchers, authors and ... ‘Open Access Week’ by actively contributing their research ... Journals from 20-26th October, 2014. , Pharmaceutical ... accelerating with a tremendous speed to provide improved ... industry is gearing with innovation and technological revolution ...
Breaking Biology Technology:Kultevat obtains license of gene switch technology 2Merck Animal Health to market Neogen's dairy genomic program 21974 - 2014 - Mapi fête ses 40 ans 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 2Pharma and Omics Journals to Address Global Challenges during Open Access Week 3
... Feb. 21 AstraZeneca,believes this lawsuit is legally and ... Supreme Court, if the trial court does not reject ... premise that the,Alabama State Medicaid Agency did not understand ... We believe numerous errors occurred during the proceedings ...
... Today, Nycomed US Inc.,successfully completed the acquisition ... therapeutic markets in the United States. With,this acquisition, ... offered through its PharmaDerm Division and thereby increase,market ... Fougera,Division, which is a leader in the topical ...
... Cardinal Health, a,global provider of products and services ... announced an order by the New York,Department of Health ... expanding statewide plan to maintain emergency response readiness, New,York ... over the past two years., Cardinal Health has ...
Cached Biology Technology:Nycomed US Inc. Acquires Bradley Pharmaceuticals, Inc. 2New York Strengthens Emergency Preparedness with Cardinal Health Ventilators 2
...
Agarose for baculovirus plaque assays which allow optimal growth of plated insect cells....
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Mycoplasma and virus tested...
Biology Products: